Risk of relapse after vedolizumab withdrawal in Inflammatory Bowel Disease for patients in histological remission

被引：0
|
作者：
Blad, W. [1 ]
Whitley, L. [1 ]
Harrow, P. [1 ]
机构：
[1] Univ Coll London Hosp, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P808
引用
收藏
页码：942 / 942
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
    Blad, William
    Whitley, Lisa
    Harrow, Paul
    GUT, 2023, 72 (SUPPL_2) : A87 - A88
  • [2] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Iborra, Marisa
    Herreras, Julia
    Maia Bosca-Watts, Marta
    Cortes, Xavier
    Trejo, Galo
    Cerrillo, Elena
    Hervas, David
    Minguez, Miguel
    Beltran, Belen
    Nos, Pilar
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1612 - 1621
  • [3] Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission
    Iborra, M.
    Navarro, B.
    Cortes, X.
    Bosca, M.
    Blazquez, T.
    Herreras, J.
    Trejo, G.
    Beltran, B.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S333 - S334
  • [4] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Marisa Iborra
    Julia Herreras
    Marta Maia Boscá-Watts
    Xavier Cortés
    Galo Trejo
    Elena Cerrillo
    David Hervás
    Miguel Mínguez
    Belén Beltrán
    Pilar Nos
    Digestive Diseases and Sciences, 2019, 64 : 1612 - 1621
  • [5] Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease
    Ranjan, M. K.
    Vuyyuru, S. K.
    Kante, B.
    Kumar, P.
    Mundhra, S. K.
    Golla, R.
    Sharma, R.
    Sahni, P.
    Das, P.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I330 - I331
  • [6] Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease
    Ranjan, M. K.
    Vuyyuru, S. K.
    Kante, B.
    Kumar, P.
    Mundhra, S. K.
    Golla, R.
    Sharma, R.
    Sahni, P.
    Das, P.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I330 - I331
  • [7] Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
    Mukesh Kumar Ranjan
    Sudheer Kumar Vuyyuru
    Bhaskar Kante
    Peeyush Kumar
    Sandeep K. Mundhra
    Rithvik Golla
    Raju Sharma
    Peush Sahni
    Prasenjit Das
    Govind Makharia
    Saurabh Kedia
    Vineet Ahuja
    International Journal of Colorectal Disease, 2022, 37 : 1817 - 1826
  • [8] Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
    Ranjan, Mukesh Kumar
    Vuyyuru, Sudheer Kumar
    Kante, Bhaskar
    Kumar, Peeyush
    Mundhra, Sandeep K.
    Golla, Rithvik
    Sharma, Raju
    Sahni, Peush
    Das, Prasenjit
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (08) : 1817 - 1826
  • [9] THIOPURINE WITHDRAWAL DURING REMISSION IN INFLAMMATORY BOWEL DISEASE: RELAPSE AND RECAPTURE RATES IN 72 PATIENTS
    Heather
    Wade, Katharine
    Radhakrishnan, Parvathy
    McLaughlin, Simon
    GUT, 2019, 68 : A60 - A60
  • [10] Risk of Relapse After Azathioprine (AZA) Discontinuation in Inflammatory Bowel Disease (IBD) Patients in Maintained Remission
    Iborra, Marisa
    Herreras, Julia
    Bosca-Watts, Marta M.
    Cortes, Xavier
    Navarro, Belen
    Martinez, Maria Teresa Blazquez
    Trejo, Galo A.
    Beltran, Belen
    Nos, Pilar
    GASTROENTEROLOGY, 2016, 150 (04) : S442 - S442
12345